Protective Effects of Puerarin Against Aß40-induced Vascular Dysfunction in Zebrafish and Human Endothelial Cells.

Xi-Lin Lu,Jun-Xiu Liu,Qi Wu,Si-Mei Long,Min-Ying Zheng,Xiao-Li Yao,Huixia Ren,Yong-Gang Wang,Wei-Wei Su,Raymond Tak Fai Cheung,Jin-Sheng Zeng,Huanxing Su,Zhong Pei

DOI: https://doi.org/10.1016/j.ejphar.2014.03.030

IF: 5.195

2014-01-01

European Journal of Pharmacology

Abstract:Aß40-induced vascular dysfunction has been implicated in the pathogenesis of Alzheimer׳s disease (AD). In the present study, we investigated the possible protective effects of puerarin against Aß40-induced vascular damage and impairment to angiogenesis in transgenic TG (fli1:EGFP) zebrafish and human endothelial cells. Aß40 peptides at 5μM caused an obvious reduction of vessel branches in the subintestinal vein basket, induced NADPH oxidase-derived reactive oxygen species and impaired vascular endothelial growth factor (VEGF)-dependent angiogenesis. Pretreatment with puerarin attenuated Aβ40-induced vessel reduction and impairment to angiogenesis in a dose-dependent manner. In addition, Aß40 decreased VEGF-dependent phosphorylation of Akt and eNOS, whereas puerarin treatment attenuated these detrimental effects. Furthermore, the restoration of Aß40-induced-angiogenesis impairment by puerarin was abolished by either the PI3 kinase inhibitor LY294002 (10μM) or eNOS inhibitor L-NAME. The present study suggests that puerarin exerts its protective action probably through reduction of NADPH oxidase-derived reactive oxygen species overproduction and activation of the PI3K/Akt/eNOS pathways.